Concepedia

Matthias Langenfeld

ML

20

Publications

1.6K

Citations

18

H-Index

1995

Active since

Affiliations

Friedrich-Alexander-Universität Erlangen-Nürnberg(Current)

Institut für Klinische Forschung und Entwicklung

The University of Sydney

Takeda (Japan)

Philipps University of Marburg

Matthias Langenfeld is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in medicine, physiology, and cardiovascular disease.

Top concepts

Publications per year

1995–2005

20

Publications

20

Improvement of Cardiovascular Risk Markers by Pioglitazone Is Independent From Glycemic Control

Andreas Pfützner, Nikolaus Marx, G Lübben et al. · Journal of the American College of Cardiology · 2005 · 270 citations

, , +8

Pioglitazone Decreases Carotid Intima-Media Thickness Independently of Glycemic Control in Patients With Type 2 Diabetes Mellitus

Matthias Langenfeld, Thomas Först, C Hohberg et al. · Circulation · 2005 · 262 citations · Full text

Increased Bioavailability of Nitric Oxide After Lipid-Lowering Therapy in Hypercholesterolemic Patients

Stefan John, Markus P. Schlaich, Matthias Langenfeld et al. · Circulation · 1998 · 239 citations · Full text

Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance.

Andreas Pfützner, Matthias Langenfeld, T. Kunt et al. · PubMed · 2003 · 165 citations

, , +16

Angiotensin II Related to Sodium Excretion Modulates Left Ventricular Structure in Human Essential Hypertension

Roland E. Schmieder, Matthias Langenfeld, Anja Friedrich et al. · Circulation · 1996 · 147 citations

Rows per page

1–5 of 20